Price alert —
Sign in to get a one-time email the moment IMUX crosses your price. Free accounts included.
Sign in / create a free accountPrice chart
Loading…
Latest bar · IMUX
Momentum reads · latest daily barGreen means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.
Financial overlay · last 12 quarters
The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.
| Quarter | Revenue | Net income | Op income | FCF | Net margin | Op margin |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | $-0.0B | $-0.0B | $-0.0B | — | — |
| 2025-12-31 | — | $-0.0B | $-0.0B | $-0.0B | — | — |
| 2025-09-30 | — | $-0.0B | $-0.0B | $-0.0B | — | — |
| 2025-06-30 | — | $-0.0B | $-0.0B | $-0.0B | — | — |
| 2025-03-31 | — | $-0.0B | $-0.0B | $-0.0B | — | — |
| 2024-12-31 | $nanB | $nanB | $nanB | $nanB | nan% | nan% |
Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.
Compare IMUX vs peers
Line IMUX up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.
Add tickers to compare with IMUX
~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.
Earnings replay · last 20 reports
How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.
| Date | EPS actual | EPS est | Surprise | Next-day |
|---|---|---|---|---|
| 2026-05-13 | -1.08 | -0.96 | -12.8% | -2.3% |
| 2026-02-26 | -0.70 | -1.11 | +37.0% | +7.6% |
| 2025-11-13 | -1.30 | -1.77 | +26.4% | +9.3% |
| 2025-08-07 | -2.00 | -1.58 | -26.3% | -3.3% |
| 2025-05-15 | -2.50 | -2.40 | -4.2% | -3.5% |
| 2025-03-31 | -2.50 | -2.38 | -4.9% | -2.3% |
| 2024-11-07 | -2.40 | -2.18 | -9.9% | +0.0% |
| 2024-08-08 | -2.10 | -2.33 | +9.7% | -0.8% |
| 2024-05-08 | -3.00 | -2.65 | -13.2% | -2.4% |
| 2024-02-22 | -4.80 | -5.40 | +11.1% | +0.0% |
| 2023-11-14 | -5.10 | -5.07 | -0.5% | +1.0% |
| 2023-08-03 | -5.40 | -5.12 | -5.4% | -5.6% |
| 2023-05-11 | -5.80 | -4.80 | -20.8% | -4.4% |
| 2023-02-23 | -5.88 | -7.42 | +20.8% | -4.1% |
| 2022-11-03 | -6.90 | -6.95 | +0.7% | -3.8% |
| 2022-08-04 | -7.20 | -7.30 | +1.4% | +11.3% |
| 2022-05-10 | -7.40 | -7.57 | +2.3% | -4.7% |
| 2022-02-24 | -8.06 | -7.58 | -6.3% | -0.3% |
| 2021-11-04 | -7.60 | -7.52 | -1.1% | -0.5% |
| 2021-08-06 | -8.20 | -6.67 | -23.0% | +6.2% |
Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.
Peer comparison · Healthcare
Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.
| Ticker ⇅ | Mkt cap ⇅ | P/E ⇅ | Fwd P/E ⇅ | P/S ⇅ | EV/EBITDA ⇅ | P/B ⇅ | Gross M ⇅ | Rev gr ⇅ | EPS gr ⇅ | FCF yld ⇅ |
|---|---|---|---|---|---|---|---|---|---|---|
| IMUX ★ | $0B | — | -4.3 | — | -0.2 | 1.4 | — | — | — | -20.04% |
| LLY | $1,051B | 41.8 | 26.3 | 14.6 | 30.1 | 33.8 | 82.8% | 55.5% | 169.9% | 0.87% |
| UNH | $387B | 32.1 | 19.2 | 0.9 | 17.7 | 4.0 | 19.5% | 0.4% | 61.5% | 5.88% |
| JNJ | $609B | 29.3 | 19.7 | 6.2 | 18.4 | 7.5 | 68.1% | 6.6% | -1.0% | — |
| MRK | $315B | 36.0 | 13.2 | 4.8 | 12.1 | 6.9 | 76.7% | 4.9% | — | 4.46% |
| ABBV | $450B | 124.8 | 15.6 | 7.2 | 17.2 | -67.6 | 72.0% | 12.4% | -46.2% | 4.63% |
| PFE | $143B | 19.1 | 8.8 | 2.3 | 7.6 | 1.6 | 74.8% | 5.4% | -10.1% | 8.67% |
| TMO | $198B | 29.2 | 19.5 | 4.4 | 21.1 | 3.8 | 40.9% | 6.2% | 11.3% | 2.79% |
Auto-seeded from sector. Click any ticker to switch.
Ownership
Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.
Top institutional holders
Top-10 concentration: 40.53%
| Holder | Shares | % out |
|---|---|---|
| Marshall Wace LLP | 952,966 | 7.00% |
| Aberdeen Group plc | 824,394 | 6.05% |
| BVF Inc. | 765,297 | 5.62% |
| Avidity Partners Management, LP | 669,941 | 4.92% |
| Vanguard Capital Management LLC | 513,832 | 3.77% |
| Soleus Capital Management, L.P. | 450,000 | 3.30% |
| Laurion Capital Management, LP | 388,216 | 2.85% |
| Millennium Management Llc | 377,992 | 2.77% |
| Morgan Stanley | 328,854 | 2.41% |
| Nantahala Capital Management, LLC | 250,649 | 1.84% |
Insider activity · 90d
7 buys / 0 sells · ratio 7.0 · Finnhub
- Skerjanec Simona BUY 25,370
- Rudick Richard Alan BUY 25,370
- Neermann Joerg BUY 25,370
- Congleton Jon BUY 25,370
- PHILLIPS BARCLAY A BUY 25,370
- Lundgren Erik BUY 1,000,000
- Panzara Michael A. BUY 300,000
Analyst estimates
FinnhubWhat Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.
SEC filings
The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.
| Form | Filed | Description | Action |
|---|---|---|---|
| 8-K | 2026-07-14 | Material event (8-K) | view · |
| 4 | 2026-07-07 | Insider transaction (Form 4) | view · |
| 4 | 2026-07-07 | Insider transaction (Form 4) | view · |
| 4 | 2026-07-07 | Insider transaction (Form 4) | view · |
| 4 | 2026-07-07 | Insider transaction (Form 4) | view · |
| 4 | 2026-07-07 | Insider transaction (Form 4) | view · |
| 8-K | 2026-07-06 | Material event (8-K) | view · |
| 4 | 2026-06-29 | Insider transaction (Form 4) | view · |
| 4 | 2026-06-29 | Insider transaction (Form 4) | view · |
| 4 | 2026-06-29 | Insider transaction (Form 4) | view · |
| 4 | 2026-06-29 | Insider transaction (Form 4) | view · |
| 4 | 2026-06-29 | Insider transaction (Form 4) | view · |
| 4 | 2026-06-29 | Insider transaction (Form 4) | view · |
| 4 | 2026-06-29 | Insider transaction (Form 4) | view · |
| 4 | 2026-06-29 | FORM 4 | view · |
| 4 | 2026-06-29 | Insider transaction (Form 4) | view · |
| 4 | 2026-06-29 | Insider transaction (Form 4) | view · |
| 8-K | 2026-06-29 | Material event (8-K) | view · |
| 4 | 2026-06-01 | Insider transaction (Form 4) | view · |
| DEF 14A | 2026-05-29 | Proxy statement | view · |
| 8-K | 2026-05-28 | Material event (8-K) | view · |
| 8-K | 2026-05-27 | Material event (8-K) | view · |
| 8-K | 2026-05-19 | Material event (8-K) | view · |
| 8-K | 2026-05-13 | Material event (8-K) | view · |
| 10-Q | 2026-05-13 | 10-Q | view · |
| 4 | 2026-04-29 | Insider transaction (Form 4) | view · |
| 8-K | 2026-04-28 | Material event (8-K) | view · |
| 8-K | 2026-04-23 | Material event (8-K) | view · |
| 8-K | 2026-04-14 | Material event (8-K) | view · |
| 8-K | 2026-04-10 | Material event (8-K) | view · |
| 8-K | 2026-04-01 | Material event (8-K) | view · |
| 8-K | 2026-03-31 | Material event (8-K) | view · |
| DEF 14A | 2026-03-02 | Proxy statement | view · |
| 10-K | 2026-02-26 | 10-K | view · |
| 8-K | 2026-02-26 | Material event (8-K) | view · |
| 8-K | 2026-02-13 | Material event (8-K) | view · |
| 8-K | 2026-01-06 | Material event (8-K) | view · |
| 8-K | 2026-01-05 | Material event (8-K) | view · |
| 8-K | 2025-11-13 | Material event (8-K) | view · |
| 10-Q | 2025-11-13 | 10-Q | view · |
| 8-K | 2025-09-25 | Material event (8-K) | view · |
| 10-Q | 2025-08-07 | 10-Q | view · |
| 8-K | 2025-08-07 | Material event (8-K) | view · |
| 4 | 2025-07-18 | FORM 4 | view · |
| 4 | 2025-07-18 | Insider transaction (Form 4) | view · |
| 4 | 2025-07-18 | Insider transaction (Form 4) | view · |
| 4 | 2025-07-18 | Insider transaction (Form 4) | view · |
| 4 | 2025-07-18 | Insider transaction (Form 4) | view · |
| 8-K | 2025-07-11 | Material event (8-K) | view · |
| 8-K | 2025-06-27 | Material event (8-K) | view · |
| 4 | 2025-06-16 | Insider transaction (Form 4) | view · |
| 4 | 2025-06-09 | Insider transaction (Form 4) | view · |
| 4 | 2025-06-09 | Insider transaction (Form 4) | view · |
| 4 | 2025-06-09 | Insider transaction (Form 4) | view · |
| 4 | 2025-06-09 | Insider transaction (Form 4) | view · |
| 4 | 2025-06-09 | Insider transaction (Form 4) | view · |
| 4 | 2025-06-09 | Insider transaction (Form 4) | view · |
| 4 | 2025-06-09 | FORM 4 | view · |
| 4 | 2025-06-09 | Insider transaction (Form 4) | view · |
| 4 | 2025-06-09 | Insider transaction (Form 4) | view · |
About IMUX
Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, which is in Phase 3 clinical and phase 2 clinical development for patients with relapsing and progressive multiple sclerosis; and moderate-to-severe ulcerative colitis. The company also develops IMU-856, which is entering Phase 2 clinical trial, for the restoration of the intestinal barrier function in patients suffering from gastrointestinal diseases, such as celiac disease, inflammatory bowel disease, short bowel syndrome, irritable bowel syndrome with diarrhea, and other intestinal barrier function diseases; and IMU-381, which is in preclinical trial, for the treatment of gastrointestinal diseases. Immunic, Inc. was founded in 2016 and is headquartered in New York, New York.
Options picks · IMUX
ITM + OTM ideas from the latest scanLoading…
Congress trades · IMUX
STOCK Act disclosuresLoading…
SEC filings & insiders · IMUX
EDGAR · liveLoading…
Holders · IMUX
Institutions & insider activityLoading…